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Abstract
Aim: Veterinarians have frequently to deal with wounds to the skin, subcutis, and underlying muscle. The aim was to 
explore the application of hyaluronic acid (HA)-containing dressing on open skin wounds in dogs. The progress of healing 
was assessed by wound area reduction and two scoring scales applied in human medicine.
Materials and Methods: Ten client-owned dogs with 12 cutaneous open wounds healed by the second intention were 
included. All wounds were treated using available in commerce HA-containing wound dressing from admission to complete 
re-epithelialization. At every clinical examination, wound area and scale scoring assessments were performed.
Results: After debridement, an increased wound size was obtained while an improvement was determined by both grading 
systems. The median numbers of return to the clinic for bandage change were 5 times. The median time to complete wound 
healing was 34.5 days. The mean wound area at day 7, 14, 21, and 28 were, respectively, 90.4%, 47.7%, 22.4%, and 14.8% 
of the original size (for linear measurement) and 95.5%, 54.4%, 23.10%, and 14.8% of the original size (for software 
measurement). Regarding wound healing assessment tools, the agreement between two operators was considered high for 
both scales.
Conclusions: HA-containing dressing may be a possible wound treatment for cutaneous open wounds in dogs. The 
assessment of wound quality using scale scoring system could be useful especially in the 1st week and to direct clinical 
decision-making process.
Keywords: advance wound dressing, canine, wound assessment.
Introduction
Cutaneous wound is by definition a break or loss 
of cellular and anatomic continuity of the skin [1]. Many 
are the possible cause involved in the development of 
cutaneous wounds in small animal, including bites, 
car accidents, lacerations from sharp objects, bullets, 
sticks, burns, and tumor excisions [1,2]. Veterinarians 
have frequently to deal with wounds to the skin, sub-
cutis, and underlying muscles and even if most wounds 
heal uneventfully one of the first questions that a cli-
nician should answered is if, when and how close the 
defect [1,2]. The most satisfactory outcome in wound 
management is undoubtedly to achieve healing by pri-
mary closure [3]. However in many cases, a second 
intention healing with contraction and epithelializa-
tion is required [1,3]. This often happened in presence 
of large traumatic injuries when there is an abundant 
amount of devitalized tissue, infection or contamina-
tion but also in case of excessive tension on the wound 
margins after aggressive soft tissue surgery involving 
skin layers, even as defect leaved by the surgeons or 
developed as wound healing complication [3-5].
Wound healing is a dynamic process composed 
by the sequence of different phases: Inflammation, 
proliferation, and maturation [1]. The management of 
the wound varies according to wound stage and gen-
erally includes irrigation, mechanical, and chemical 
debridement, adherent and non-adherent dressing and 
a range of topical medication [6]. Recently in veter-
inary medicine, many studies have been focused on 
wound care. In addition, data have been published 
especially about new healing strategy, techniques, and 
products such as the use of advance medical dressing 
and negative pressure therapy with the goal to accel-
erate the healing process [7-14].
Hyaluronic acid (HA) is a glycosaminoglycan 
consisted of a basic unit of two sugars, glucoronic and 
N-acetyl-glucosamine, that forms a part of the extra-
cellular matrix [15]. HA is conserved throughout all 
mammals and is found in high concentrations in sev-
eral soft connective tissue including skin [16]. In fact, 
HA plays a vital role in maintaining tissue integrity, as 
well as in facilitating adhesion and differentiation of 
cells during inflammation, wound repair, and embry-
onic development [17,18]. Many in-vitro and in-vivo 
studies confirmed that HA is closely involved in fibro-
blast proliferation, enhanced formation of granulation 
tissue and angiogenesis, and even in keratinocyte 
proliferation and migration during wound healing 
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process [17-21]. These promising results associate 
with a non-immunogenic response and its degradation 
by natural, non-inflammatory clearance mechanisms 
have led to the development of a range of wound dress-
ing containing HA for human medical use [16,22-26]. 
In veterinary medicine, the information about the use 
of HA as a part of wound management is little, and 
nowadays, the benefit results of this molecule applica-
tion on wound healing as a cross-linked HA-based gel 
in experimental dog court are still controversial [8,9].
One of the problems encountered in the evalu-
ation of the healing process is also how to evaluate 
it. The end point of the healing process is to obtain 
the restitutio ad integrum of the skin layer, and the 
progressive reduction of wound area is the mainstay 
parameter to assess. Otherwise in recent veterinary 
studies, the addition of other factors such as charac-
teristics of the wound bed and of the periwound tissue 
have been discussed as other quality parameters for 
verifying the healing process and also the wound care 
therapy application [9,13]. This kind of evaluation 
using scale scoring system in human medicine, par-
ticularly for chronic wounds, is well known even if a 
gold standard method is not available [27-29].
Due to the little information on literature, the aim 
of this study was to collate a sample of canine patient 
with full-thickness skin wounds healed by second 
intention and to explore on theme the use of available 
in commerce HA-containing wound dressing, detail-
ing the difficulties, adverse events, costs, and wound 
outcome. In addition to wound dimensions, the pro-
gresses of the wounds were also followed using two 
wounds assessment scales borrowed from the human 
medicine that quantitatively described the status of 
salient physiologic wound characteristics.
Materials and Methods
Ethical approval
This study was performed at the Department of 
Veterinary Science and Public Health of the University 
of Milan and it did not include experimental animals 
and it was performed on client-owned dogs referred 
to our institution for therapeutic purpose. All own-
ers gave us the consensus for treatments, measure-
ments and for data recording. All clinical procedures 
were performed in according with Italian law (DL 
14th march 2014 n.26) and Europe Union legislation 
covering the use of animals for scientific purpose 
(“Animal Scientific Procedures Act” 63/2010/EU).
Inclusion criteria and measurement methods
Animals prospectively included in the study 
were client-owned dogs with cutaneous open wounds 
healed completely by only second intention consecu-
tively referred from January 2013 to February 2014. All 
wounds had at least a full-thickness skin lost and were 
treated using available in commerce HA-containing 
wound dressing from the date of admission to the date 
of complete re-epithelialization. Due to the absence 
of specific veterinary formulation in our country, 
HA-based medications available in commerce for 
human medicine were used, and informed owner con-
sent was obtained for each dog. The complete re-ep-
ithelialization was assessed independently by two 
veterinary surgeons. All animals included had to be 
followed-up at least until complete re-epithelializa-
tion of the wound. Any wound in which was achieved 
a primary, a delayed primary or the secondary closure 
were excluded from the study.
All dogs included underwent a physical exam-
ination before starting any evaluation and treatment of 
the wound. For patients referred for traumatic injuries 
any possible reason of life-threatening were excluded 
or managed before starting cutaneous open wound 
evaluation.
Other data recorded in the clinical record 
were: Signalment, weight and body condition score 
(BCS - scoring from 1 to 5) [30], etiology (if known), 
site of the lesion, complete blood sample evalua-
tion (complete blood count, biochemistry), any con-
comitant drugs administration (e.g. corticosteroids, 
anti-blastic therapy), and any concomitant disease 
(e.g. bone fracture, cavitary collections, metabolic, 
or endocrinologic disease). If referring veterinarian 
had already treated a wound before referred it, type of 
treatment and timing of treatment were recorded.
The wound area was calculated using two 
methods. First, each wound has been approximated 
to a rectangular figure, and the area was calculated 
multiply the two maximum perpendicular diameters 
measured in a bi-dimensional representation. The two 
measures were achieved using a digital caliper or in 
presence of wound above the curves of the body whit 
a soft meter and the limits for the evaluation of the 
diameters were the macroscopic margins of epithelial 
tissue. Secondary, a digital photograph of the wound 
was obtained at each clinical control and uploaded in 
a wound tracing software program (NIH ImageJ soft-
ware, http://rsb.info.nih.gov/nih-image/) that calcu-
lated the wound area. For both methods, wound area 
was interpreted as 100% on admission and the areas 
on subsequent controls were expressed as a percent-
age of admission value using the formula:
 At/A0*100
Where, A0 is the area on admission and At is the 
wound area on control date.
All wounds included in the study were also pro-
spectively classified at admission and during healing 
process by means of two scale scoring systems, Bates-
Jensen Wound Assessment Tool (BWAT) and wound 
bed scoring (WBS) [28,31-34]. The BWAT includes 
4 parameters scoring from 0 to 5 (size, depth, edges, 
undermining) and 9 parameters scoring from 1 to 5 
(necrotic tissue - type and amount, exudate - type 
and amount, surrounding skin color, peripheral tis-
sue - edema and induration, granulation tissue, epi-
thelialization). The wound assessment results by 
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adding the score of each parameter from a minimum 
of 9 (the best score) to a maximum of 65 (the worst 
score) [28,31-33]. The WBS comprised an evalua-
tion of 8 parameters (black eschar - eczema/derma-
titis - depth - scarring - color of wound bed - edema/
swelling - resurfacing epithelium - exudate amount) 
scoring from 0 to 2. Using this scale a wound could 
range from a maximum of 16 (the best score) to a min-
imum of 0 (the worst score) [34]. In both scales in 
the presence of multiple features of the same parame-
ter the worst score was reported. Two surgeons inde-
pendently performed the assessments. The quality 
and type of exudate were evaluated on the basis of 
how the removed bandage looked like while all other 
parameters were assessed after irrigation (with saline) 
by means of 20 ml syringe and a gentle sterile gauze 
sponges handing with the purpose to remove the 
superficial biofilm.
Because wound healing is a dynamic pro-
cess, all wounds were prospectively managed with 
HA-containing dressing based on TIME princi-
ples [35] in according to the characteristics of the 
open wound and also to manufacture’s instruction. In 
presence of necrotic tissue (BWAT amount of necrotic 
tissue score ≥2 and/or WBS black Eschar score ≤1) a 
debridement (surgical sharp debridement [SD] and/or 
medical debridement [MD]) were always applied. The 
MD consisted of HA plus collagenase-based topical 
enzymatic debridement agent (Bionect Start®, Fidia 
Farmaceutici S.p.A., Abano Terme - PD, Italy) or a 
HA plus sodium alginate sterile micro-granules medi-
cation (Hyalogran®, Fidia Farmaceutici S.p.A., Abano 
Terme - PD, Italy). In absence of macroscopic necrotic 
tissue (BWAT amount of necrotic tissue score = 1 and 
WBS black eschar score = 0) an adsorbent medication 
made of partial benzyl ester derivative of hyaluro-
nan (Hyalofill-F®, Fidia Farmaceutici S.p.A., Abano 
Terme - PD, Italy) was used when granulation tissue 
was forming or, when wound did not include deep tis-
sue damage, a daily application of a spray composed 
by HA plus silver (Hyalosilver®, Fidia Farmaceutici 
S.p.A., Abano Terme - PD, Italy) was applied. When 
the open wound was entirely filled by granulation tis-
sue (BWAT granulation tissue score = 2 and WBS color 
of wound bed = 2) the owners were instructed to daily 
apply a HA based topical medication (Connettivina®, 
Fidia Farmaceutici S.p.A., Abano Terme - PD, Italy) 
until complete epithelialization. If different and simul-
taneous features characterized different part of the 
wound a mix of this product was used. In all cases, 
the second layer of the bandage was composed by cot-
ton padding and then a third layer of the latex-coated 
cohesive bandage (Easifix Cohesive®, BSN medical, 
Vibraye, France) was applied. A tie-over bandages 
was used to fix the second layer in area difficult to 
cover (e.g. inguinal area).
First wound area and assessments evaluation 
were performed the date of the first clinical examina-
tion for traumatic and primary closure complication 
wounds (CW), or the date of surgery for excision 
wounds. After, the assessments and wound area mea-
surement were repeated at every bandage change per-
formed by clinicians. All the bandage changes were 
sterilely performed. If needed or require by the owner 
adjunctive control respect to the clinical examination 
scheduled were performed, and the cause of earlier 
evaluation was recorded. Numbers and frequency of 
wound assessment for each animal were also reported. 
In the case of surgical SD all the assessments, includ-
ing wound area measurements, were performed both 
before and after to evaluate the impact of the surgical 
procedure. When owners applied the HA-medications 
at home, a weekly clinical examination to assess the 
wound progress was scheduled. During each clinical 
examination, owners were asked to inform of any dif-
ficulties or disadvantage retrieved with the bandage. 
The presence of complete wound healing was assessed 
by the evaluation of the clinician and corresponded 
to a wound covered entirely by epithelial tissue in 
the absence of any sign of granulation tissue. Time 
of complete wound healing (TWH) was recorded and 
defines as the time from first assessment to complete 
re-epithelialization (100% of the wound area).
When complete re-epithelialization was assessed 
cosmetic and functional outcome were also evaluated 
and recorded in the clinical record.
During the study period, the use of antibiotic 
therapy was recorded. The use of antibiotics was 
reserved to wounds showed sign indicative of infec-
tion such as: Severe soft tissue swelling, erythema, 
pain, hyperthermia and/or purulent discharge. The 
antibiotics were chosen on the basis of anti-biogram 
results if a swab sample or a biopsy of the wound bed 
for microbiological culture was available. The anti-
biotic administration was stopped when the signs of 
infection were completely regressed, and a healthy 
granulation tissue (BWAT granulation tissue score = 2 
and WBS color of wound bed = 2) was forming.
When the animals underwent general anesthe-
sia, anesthetic protocol consisted of a multimodal 
approach including analgesic therapy. The protocol 
differed among animals, and it was calibrated on the 
basis of the clinical examination of the single animal 
and the type of procedure that had to be performed 
(surgical SD vs. bandage change). In all cases after 
surgical debridement and in every case in which 
pain was detected an analgesic therapy consisted of 
non-steroidal anti-inflammatory drug oral administra-
tion was prescribed to obtain pain relief.
Statistical anlaysis
Pattern of wound area reduction (both meth-
ods) during follow-up was evaluated by analysis of 
variance model (ANOVA) for repeated measures. 
As a pre-fixed schedule for clinical examination was 
not planned and follow-up time was heterogeneous, 
4 times which were common for all subjects were 
considered: 7, 14, 21, 28 days. To account for the 
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correlation of the measures within the same subject, 
a variable identifying subject was considered in the 
ANOVA model as random effect, whereas days was 
included as fixed effect by dummy variables (mixed 
model ANOVA). To compare the pattern of the WBS 
and BWAT with the pattern of wound area reduction 
the first two scales were transformed as percentages 
of scoring as follows. For BWAT, the score at time 
0 was considered as 100%. The maximum reduction 
for the patient was the difference between the initial 
score and the best achieved score (MR BWAT: BWAT 
at time 0-9). For each time, the difference between the 
initial score and observed score was calculated (dif-
ference BWAT). The percentage was then obtained as:
 100-(diff BWAT/MR BWAT)*100
For WBS, the score at time 0 was considered as 
100%. The maximum increase for the patient was the 
difference between the best score achieved and the 
initial score (MI WBS: 16-WBS at time 0). For each 
time, the difference between the observed score and 
the initial score was calculated (difference WBS). The 
percentage was then obtained as:
 100-(diff WBS/MI WBS)*100
The pattern of the transformed scales was then 
analyzed by mixed model ANOVA. The probability 
of reaching 0% (the best achieved score) during time 
for wound area reduction, BWAT, and WBS scores 
was estimated by Kaplan–Meier method. This method 
allowed to estimate the median time to complete wound 
area reduction (and the best achieved score of BWAT 
and WBS). Due to the low number of patients and pre-
liminary aim of this study no formal statistical test on 
ANOVA were performed. Results are reported as model 
estimated reduction and 95% confidence intervals (CI). 
No adjustment was performed by covariate effects.
The agreement between the BWAT and WBS 
scoring independently attributed to the patients by 
two veterinary surgeons was evaluated by the intra-
class correlation coefficient (ICC) based on two-way 
repeated ANOVA model with random effects.
As two methods were used to evaluate wound 
area (the approximation to a rectangular and software), 
an explorative comparison was performed on all the 
available wound measurements. No one of the two 
methods could be considered as gold standard thus the 
“exact” wound area was approximate by the average 
of the two calculated areas. The comparison was then 
examined by plotting the differences between the two 
areas measures against their average, as suggested in 
the Bland and Altman plot. Since the aim was only 
explorative no limits of agreement were calculated 
but, following a practical perspective, the percentages 
of measurements differences within defined ranges 
were reported.
Results
12 open wounds in ten dogs were enrolled in 
the study. Breeds were as follows: Mixed-breed (2), 
Jack Russel Terrier (2), Dogue de Bordeaux (1), Irish 
Wolfhound (1), Dogo Argentino (1), Whippet (1), 
Pinscher (1) and American Pit Bull Terrier (1). Four 
dogs were females (1 neutered) and 6 were males 
(2 neutered). At admission, mean age was 7.9 years 
(range 1-15 years) and mean body weight was 23.1 kg 
(range 5-47 kg). Two dogs had a BCS of 2, in 5 dogs 
the BCS was 3 and in the last 2 dogs was 4.
At admission, three dogs reported comorbidities 
related to past history: Cardiopathy (2) and diabetes 
mellitus (1). Two dogs reported in the recent clinical 
history (2 weeks or less before admission) one or more 
surgical malignant tumor excision in location not asso-
ciated to the wound: Perivascular wall tumor (1), mast 
cell tumor (1) and femoral osteosarcoma (1). One dog 
was surgically treated for a foreign body abscess of 
the mandibular region 2 weeks before admission.
The hematological parameters at admission were 
unremarkable in all but two dogs in which hypoalbu-
minemia (1) and high glucose level (1, the dog with 
diabetes mellitus) were found.
Wound data
A total of 12 wounds were included (2 dogs had 
2 simultaneous and anatomically split wounds) and 
treated with HA-based medications until complete 
re-epithelialization. All wounds were summarized in 
Table-1. The wounds were classified on the basis of 
the etiology in: Traumatic wounds (TW, 7), primary 
closure CW (2) or excised wounds (3) in presence of 
skin defect intentionally leaved by surgeon. The spe-
cific nature of trauma was reported in Table-1. Two 
TW were referred in presence of unhealthy and deteri-
orating wound appearance after 10 days of previously 
treatments: Surgical apposition of traumatized cuta-
neous margins (Table-1) and naftalina granules and 
saline solution irrigation (Table-1). Regarding wounds 
developed after malignant tumor excision, the histo-
logic margins were infiltrated in two cases (Table-1). 
No one wounds presented healthy granulation tissue 
at time to admission.
At admission, the median wound area using the 
approximation to a rectangular figure was 32 cm2 
(min 5.40, max 561). In all cases were debridement 
(SD and/or MD) was applied the wound areas had an 
average increase of 14.4 cm2 (Table-2).
At admission, the median wound area using the 
software was 22 cm2 (min 2.67, max 417.29). In all 
cases were debridement (SD and/or MD) was applied 
the wound areas had an average increase of 10.19 cm2 
(Table-2).
At admission, the median BWAT score was 32.5, 
while for WBS was 11. In the 7 wounds in which 
debridement had been applied, the median BWAT 
score improved from 38 to 32, corresponding to a 
median decrease from admission score of 6, while 
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the median WBS score improved from 8 to 11, corre-
sponding to a median increase from admission WBS 
score of 2 (Table-2).
All dogs were discharged at home the day of 
admission and returned to the clinic only for dressing 
changes and clinical controls. The median numbers of 
return to the clinic for bandage change (excluding the 
date of admission) was 5 times, (range, 4-14 times). 
When dressing was applied by the owner wounds 
were generally rechecked once a week (median, 
7 days; range, 2-16 days). When the adsorbent medi-
cation made of partial benzyl ester derivative of hyal-
uronan was applied, the dressing was always revised 
by the clinician, and bandages were generally changed 
every 4 days (median, 4 days; range, 2-7 days). In the 
2 widest TW (Table-1 and Figures-1 and -2) due to 
the amount of exudate a silver-pad foam (Cellosorb 
Silver®, Laboratoires URGO, ChenO, Cedex, France) 
was applied over the HA-based medication before 
the second layer of the bandage until scoring for the 
amount of exudate achieved 2 out of 5 for BWAT and 
2 out 2 for WBS. Due to the location and the size of 
the wounds a tie-over bandage was applied in both 
cases.
In 5 wounds (3 dogs) antibiotic therapy was 
administered. In wounds 3, 4, 5 (Table-1) a swab test 
was performed due to the presence of purulent dis-
charged and peripheral tissue erythema. In these cases 
Klebsiella pneumoniae was retrieved and an antibi-
otic protocol with marbofloxacin was started as anti-
biogram results suggested. In wounds 6 and 7, the dog 
had been already under enrofloxacin administration 
before the admission, and the protocol was continued 
until appearance of granulation tissue due to the nature 
of the lesion even if no particular signs of infection 
were presented at that moment.
Table-1: Wounds included in the study.
Wound Weight (kg) 
[BCS]
Age 
(years)
Type Cause Site Area 
(cm2)
TWH 
(days)
Concomitant 
drugs
1 38 [4] 5 TW Laceration (unknown origin) Elbow 18 24 -
2 15 [2] 1 TW Hot water pad burn Medial thigh 9.6 21 -
3 35 [3] 4 TW Laceration (unknown origin) Distal forearm 36 62 -
4 21.7 [4] 6 TW Car accident (degloving injuries) Ventral abdomen 540 75 -
5 21.7 [4] 6 TW Car accident (shear injuries) Lombar region 38.7 35 -
6 9 [4] 8 TW Electric pad burn Flank 109.6 54 -
7 9 [4] 8 TW Electric pad burn Scapular 22.5 17 -
8 45 [3] 4 EW Malignant skin 
neoplasia excision
Lateral hock 36 49 Vinblastin+
corticosteroid
9 5 [3] 14 EW Malignant skin 
neoplasia excision
Proximal medial 
forearm
15.1 28 ACE-inhibitor+
furosemide
10 6 [3] 15 EW Malignant skin 
neoplasia excision
Caudal thigh 5.4 34 ACE-inhibitor+
furosemide
11 47 [3] 11 CW Malignant skin 
neoplasia excision
Lateral thorax 32 88 -
12 9.2 [2] 11 CW Forelimb amputation for 
malignant skin neoplasia
Shoulder 10.4 21 Insulin
TWH=Time to complete wound healing, BCS=Body condition score, TW=Traumatic wounds, EW=Excised wounds, 
CW=Complication wounds
Figure-1: Wound healing evolution for wound 4, (a) Wound status at admission: A wide area of discolored tissue was 
present on the ventral side of the abdomen. The mammary tissue was mobile respect to the underlying abdominal wall. The 
patient underwent a massive surgical debridement in association with medical debridement, (b) wound status after 2 days: 
An initial deposition of granulation tissue was present. Multiple, loose, simple interrupted, monofilament, nonabsorbable 
suture were used to secure in place the medication and the bandages (tie-over bandage), (c) wound status after 19 days: 
A decrease of wound dimension was easily appreciated. All of the wound boundaries were fixed to the underlying tissue 
and at the wound margins a new epidermal edge was visible, (d) wound status at 55 days: A constant decreased of wound 
area was retrieved. The owners were instructed on the daily application of the topical medication (hyaluronic acid-based 
cream), (e) wound status at 75 days: Complete epithelialization.
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Excluding the SD that was always performed 
under general anesthesia, only for the management of 
wound 4 (Table-1) sedation was performed at every 
bandage change (every 3 days) until day 10 from 
admission. This was the widest wound and for clinical 
control the dorsal recumbency was necessary creat-
ing particular discomfort for the dog during this initial 
period. All other bandage changes in this dog and all 
bandage changes in the other patients were performed 
with wakeful dogs.
All the products were well tolerated by dogs, and 
no side effect was retrieved. Only one dog was prone 
to removing the bandage, and earlier returns to the 
clinic than scheduled were necessary also because the 
owner did not follow the suggestion to use Elizabethan 
collar (Table-1). Some owners complained the pres-
ence of an unpleasant odor of the bandage. This was 
correlated to high amount of exudate and breaks down 
of the HA-based products but not to infection as also 
assessed by the improvement of the wound status. 
When spray formulation was used, owners reported 
that some dogs felt a little uncomfortable sensation 
due to the noise. The cosmetic result was considered 
good even if in all cases an alopecia area of different 
dimension has been retrieved. In addition, the skin in 
this area looks thinner and in some cases hyper-pig-
mented but no complication was reported related to 
these condition. No range motion alteration due to 
contracture were observed even for wounds located 
close to flank, axillar or other joint, and the functional 
outcome was judged great in all dogs.
Outcome
The median TWH was 34 days. The 0.25, 0.50, 
and 0.75 cumulative probability to be healed in this 
study was reached at 21, 34, and 54 days, respec-
tively (Figure-3). No wounds were considered healed 
at 14 days, 3 were considered healed within 21 days 
(cumulative probability of healing: 0.25; 95% CI: 
0-0.46), 5 wounds within 28 days (cumulative proba-
bility of healing: 0.42; 95% CI: 0.06-0.64), 7 wounds 
within 35 days (cumulative probability of healing 
0.58; 95% CI: 0.19-0.79), and 10 wounds within 
63 days (cumulative probability of healing 0.83; 95% 
CI: 0.41-0.95) (Table-1).
In all wounds the best BWAT score was achieved 
at the same date when clinician assessed the complete 
healing. Eleven out of 12 wounds achieved the min-
imum BWAT score of 9 while 1 wound achieved the 
score of 10. The pattern of cumulative probability to 
achieve the best BWAT score was superimposable 
to that previously reported for wound area reduction 
(Figure-3).
Considering the WBS scale, the 0.25, 0.50, and 
0.75 cumulative probability to achieve the best WBS 
score was reached at 9, 14, and 35 days, respectively 
(Figure-3). Two wounds reached the best WBS score 
within 7 days (cumulative probability 0.17; 95% CI: 
0.00-0.35), 6 wounds reached the best WBS score Ta
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within 14 days (cumulative probability 0.50; 95% 
CI: 0.12-0.72), 7 wounds reached the best WBS score 
within 21 days (cumulative probability 0.58; 95% 
CI: 0.19-0.79) and no wound further reached the best 
WBS score between 21 and 28 days. In all cases, the 
best score was reconfirm in the subsequent assess-
ments until complete epithelialization was achieved.
Considering the 1st month of treatment, the 
weekly mean percentages of two-axis wound area, 
software wound area, BWAT and WBS scores respect 
to admission values are illustrated in Figures-4-7, 
respectively.
When another clinician applied both scoring 
systems, the agreement between the two operators 
was considered good with an ICC of 0.88 for WBS 
(95% CI: 0.83-0.91) and of 0.95 for BWAT (95% CI: 
0.93-0.97).
Regarding the comparison between area mea-
surement with rectangular and software method, over-
all 107 measurements were performed with both the 
methods. Since 12 measurements for both method 
reported 0% at the time of complete healing, only the 
other 95 remaining measures were considered. As the 
differences between methods were related to the area, to 
facilitate the comparison data were subdivided accord-
ing to the following categories: Areas <10 cm2 (28.4% 
of the data), areas between 10 and 25 cm2 (29.5% of 
the data), areas between 25 and 50 cm2 (17.9% of the 
data), areas between 50 and 100 cm2 (11.6% of the 
data) and areas beyond 100 cm2 (12.6% of the data). 
Measurements with rectangular approximation tend to 
be greater than measurements with software and the 
differences between the two measurements tends to 
increase with the increasing of the area (Figure-8).
Discussion
The roles of HA in each phase of wound healing 
have been investigated intensively in human medicine, 
and HA’s properties have recently been successfully 
used in a number of wound dressing [28,36]. In veter-
inary medicine the potential for using HA-based med-
ication on open skin wound in dogs was studied only 
by two case-control papers in which a cross-linked 
HA was applied on small (2 cm × 2 cm) experimen-
tal open wounds. In those studies controversial results 
were obtained and also taking into account the positive 
experience of human medicine, the additional investi-
gation should be reached to increase the knowledge 
of HA properties also for companion animals [8,9]. 
In addition, medical experimental research does not 
Figure-3: Cumulative probability to be healed considering 
complete wound area reduction and to reach the best 
Bates-Jensen Wound Assessment Tool and wound bed 
scoring scores during time.
Figure-4: Mean percentage of “two-axis” wound area 
respect to T0 during the 1st month of treatment. The mean 
percentage of wound area at day 7 was 90.41% (95% 
confidence interval [CI]: 77.38-103.4), at day 14 was 
47.74% (95% CI: 34.72-60.8), at day 21 was 22.38% 
(95% CI: 9.36-35.4) and at day 28 was 14.81% (95% 
CI: 1.78-27.8) of the original size.
Figure-2: Wound healing evolution for Wound 6 and 7, (a) Wound status at admission: Two areas of discolored tissue were 
present on the right lateral side of the trunk (wound 6 on the flank and wound 7 on the scapular region). The two wounds 
were filled by a dry black and yellow eschar. Both wounds were treated with medical debridement. For wound 6 a tie-over 
bandages was applied, (b) wound status after 4 days: The eschars became an easy to remove yellow non-fixed mushy 
necrotic tissue. An initial pink granulation tissue was present under the necrotic tissue. Multiple, loose, simple interrupted, 
monofilament, non-absorbable suture were used to secure in place the medication and the bandages for the wound on the 
flank (tie-over bandage), (c) wound status after 15 days: A decrease of wound dimension was easily appreciated. Wound 
7 was almost complete epithelialized. The bottom of the wound 6 was filled by a healthy red granulation tissue, (d) wound 
status at 54 days: A complete epithelialization of the wound 6 was achieved.
dcba
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always replicate clinical conditions [36] such as the 
presence of comorbidities or peripheral tissue damage 
that impair the healing process as happen instead in 
all non-experimental wounds making those results’ 
studies potentially no reproducible in the clinical set-
ting. Regarding these issues, the use of HA-containing 
dressings was evaluated for the first time on a small 
cohort of non-experimental cutaneous open wounds 
in client-owned dogs.
The commercial available HA formulations 
tested in this study were found easy to apply, with-
out the need of intensive staff training and so could 
be used not only in a veterinary second opinion hos-
pital but even in an ambulatory setting. The formu-
lations in gauze, cream, granules and spray allowed 
to apply the medication also in the presence of very 
irregular shape and inside the undermined pocket. 
The bandages were applied as routine so dogs were 
able to stay at home and to live a regular life with the 
exception of takes care of bandages (e.g. T-shirt cov-
ering the bandage, Elizabethan collar). Owners were 
instructed to re-build the bandages only when the 
wounds were in the late stage of progression, and no 
problems were recorded at the weekly examination 
using this strategy. In fact, the formulations in cream 
and spray were also described for auto-medication for 
human beings.
No side effects on wounds and periwounds tis-
sue were recorded in the present study. This finding is 
in according with the past literature in which no side 
effect and no allergic response were reported for the 
topical application of HA in wounds, both for dogs and 
human [8,9,22,37,38]. Hadley and colleagues histo-
logically proved the absence of inflammatory reaction 
around the HA-based gel applied on their experimen-
tal wounds in dogs [9]. The unpleasant odor reported 
by some owners associated with the HA products used 
in the present study was otherwise tolerated and has 
been related to the degradation of HA associated to 
the presence of wound fluid. To bypass the uncom-
fortable sensation linked to the use of spray, owners 
were instructed to not use it directly on the wound but 
to drench sterile gauze and to apply it on the wound.
The frequency between each dressing change 
varied widely and was mostly influenced by type of 
dressing and characteristic of the wound at assess-
ment. The adsorbent medication made of partial 
benzyl ester derivative of hyaluronan was re-applied 
every about 4 days even if for human medicine this 
product could be leave until for a week. This medi-
cation breaks down in contact with wound exudate 
forming a gel rich of HA. The degradation timing 
depends on exudate levels and when at the assess-
ment wound achieved a high exudate score the dress-
ing change was scheduled more frequent than weekly. 
At the same time clinician had to consider this deg-
radation and gel forming when evaluated the type 
and amount of exudate, especially when the bandage 
was early changed and the product was not totally 
adsorbed. It may be possible that this consideration 
has led to a more frequent dressing change in the first 
Figure-5: Mean percentage of software wound area 
respect to T0 during the 1st month of treatment. The 
mean percentage of wound area at day 7 was 95.5% 
(95% confidence interval [CI]: 77.33-113.8), at day 14 
was 54.4% (95% CI: 36.22-72.6), at day 21 was 23.10% 
(95% CI: 4.89-41.3) and at day 28 was 14.79% (95% 
CI: −3.42-33) of the original size.
Figure-6: Mean percentage of initial Bates-Jensen Wound 
Assessment Tool score (BWAT) during the 1st month of 
treatment. The mean percentage of BWAT score at day 7 
was 66.15% (95% confidence interval [CI]: 54.7-77.6), at 
day 14 was 51.96% (95% CI: 40.5-63.4), at day 21 was 
32.63% (95% CI: 21.1-44.1) and at day 28 was 21.70% 
(95% CI: 10.2-33.2) of the admission score.
Figure-7: Mean percentage of initial wound bed scoring 
(WBS) score during the first month of treatment. The 
mean percentage of WBS score at day 7 was 47.71% 
(95% confidence interval [CI]: 27.86-59.6), at day 14 was 
22.38% (95% CI: 6.52-38.2), at day 21 was 14.38% (95% 
CI: 0-30.2) and at day 28 was 11.43% (95% CI: 0-27.3) 
of the admission score.
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wounds treated respect to the last when a good mas-
tery of the product was achieved.
One factor that should be taken into account in 
the choice of dressing is the cost benefits and even, 
for veterinary practitioners, the easy availability also 
for not hospital facility. The HA-containing dressings 
used in this study are available in any drug store of 
the country and have a cost range from of about 30 
(gauze, 10 cm × 10 cm) to 10 euro (15 g cream tube) 
at which should be added the regular cost for bandage 
materials and clinical control. Obviously, the cost 
increases with increasing size of treated area and with 
the need of more than one product. On the contrary, 
the increased cost of an advance medical dressing has 
to be set against a shorter period of treatment and also 
to the lack of need of hospitalization for the type of 
medications used in this study.
In front of these good results is mandatory to 
achieve also a good wound outcome. To test the out-
come of a wound medication a control group is always 
necessary. The explorative intent of this study, the 
small number of the sample and the difficult to build 
a control group that overlaps the characteristic of non- 
experimental wounds and patients allow to extrapolate 
only observational data. Authors considered the TWH 
(of about 1 month) achieved with HA-based dressing 
in canine non-experimental open wound a promising 
result. In particular, the wound area reduction was 
higher between 7 and 14 days with a mean wound area 
at 2 weeks halved than admission (Figures-4 and -5). 
Recently, the use of negative pressure in spontaneous 
wounds healed only by the second intention achieved 
a mean healing time of 26 days while excisional 
wound without advance dressing achieved a median 
healing time of 53 days [5,7]. Nevertheless due to the 
specific nature and features of spontaneous injuries 
any comparison with other studies that used different 
dressing or therapy involves possible high-risk bias 
and confirmation in further studies of the impact of 
the HA-medications on wound outcome is necessary.
Reading the literature on HA and wound heal-
ing seemed that HA plays a role in each phases of 
the healing process. Many studies found that HA not 
only enhance the fibroblast and vascular deposition 
in the granulation tissue, but also the keratinocyte 
proliferation during epithelialization [17-21]. Due 
to ethical implication and the clinical nature of this 
study no incisional biopsy of the healing tissues was 
sample during the present study, so was impossible to 
better elucidate the structure of the newborn tissues, 
and in addition in absence of a control group to have 
a comparison with no treated wounds. Otherwise, to 
authors’ experience and observation the granulation 
tissue filled the wound gap in a very quick period and 
generally grossly appeared of a very good and healthy 
quality making supposed that the HA have principally 
promoted the deposition of fibroblast and neo-angio-
genesis. This is also reported by another experimental 
Figure-8: Comparison of area measurement between two-axis and software methods. Panel A: Overall wound area 
measures; Panel B: Two-axis wound area measures <10 cm2; Panel C: Two-axis wound area measures ≥10 cm2 and 
<25 cm2; Panel D: Two-axis wound area measures ≥25 cm2 and <50 cm2; Panel E: Two-axis wound area measures 
≥50 cm2 and <100 cm2; Panel F: Two-axis wound area measures ≥100 cm2. An increasing trend for the discrepancy 
between the two methods with the increasing of the wound area is shown.
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study on HA in dogs, in which authors described a 
better gross appearance of the granulation tissue for 
the treated wounds [8].
Periodic wound assessment to document heal-
ing progression and effectiveness of treatment is one 
of the most important parts of wound management. 
Wounds were reassessed at every bandage change. In 
human medicine, the frequency of assessment is often 
related to specific patient and wound, with a higher 
frequency for acute than chronic wound [29]. In vet-
erinary experimental research with HA the wounds 
were re-assessed every 3 days or weekly [8,9] but no 
information on clinical setting is available. In author’s 
experience with these HA-based products the assess-
ment may be generally repeated after a period from 4 
to 7 days to detected noticeable alteration that justify 
to declare an improvement or worsening of the wound 
even if the clinician as to change early the dressing as 
happen in case of dogs prone to remove it.
Wound dimensions are the most frequent used 
parameters for healing evaluation in clinical and 
research settings [8-10,13,27]. Many are the pos-
sible measures to evaluate a dimensional assess-
ment [39]. In veterinary medicine, the majority 
of the studies referred to area for measuring the 
wound extension [8-10,13]. In experimental setting 
often digital imaging and software application have 
been used [8-10] while linear metric dimension and 
mathematical formula have been used in clinical 
research [5]. Obviously, the technique to calculate the 
wound area as a rectangular only approximates the 
real wound area that could be of irregular shape, but it 
was made because was the simplest, least expensive, 
reliable and fast method in a clinical setting [39]. On 
the other hand, this could have overestimated the real 
size of about 25% in case of circular wound area [39]. 
In fact, the two-axis methods generally represent a 
bigger wound area respect to software assessment 
also in this present study. However, this method was 
always applied, and the possible error was repeated 
during the assessments making probably correct the 
comparison of two evaluations in the same wound. To 
be more precise even the software was applied. This 
software was free, easy to use and the only necessary 
equipment is a digital camera and a personal com-
puter. However, the authors find some possible bias 
use it when the extension of the wound followed the 
natural curves of the body (e.g. wound extended for 
more than 180° around extremity) and the bi-dimen-
sional picture achieved was not able to represent the 
real extension. In these cases, the technique reported 
by Tambella et al. where the perimeter of the open 
wound area was captured by hand with a fine tip per-
manent marking pen on a transparent sheet placed 
directly on the wound bed and then photographed and 
measured with the software should be use [14]. Taking 
in consideration the difference achieved with this two 
methods (Table-3) and the absence of a gold standard, 
the method chooses at the first assessment should 
be repeated during the healing process, at least until 
the wound became small (<9 cm2) and the difference 
could be more probably <1 cm2.
The use of wound area alone in the assessment 
of wound healing progression has the disadvantage 
to do not take into account the change in the quality 
of the wound bed that not always reflect a change or 
a reduction in wound dimensions [27]. In veterinary 
medicine no data are available concerning this kind 
of assessment even if some authors discussed about 
the addition in wound judgment of other parame-
ters [14], such as fluid characteristics, granulation 
tissue, periwound, status and hidratation to subjec-
tively evaluated experimental wound in dogs [9,13]. 
Considering this, two visual wound scales previously 
used in human medicine were parallel applied at each 
assessment. In human medicine this kind of evalua-
tions were very diffuse and even if a real gold stan-
dard method is not approved, these tools represent an 
active part of wound management [27,35,40]. These 
scales are generally used and drawn for the evaluation 
of the most frequent human chronic wounds and their 
application on an acute open wound in dogs remained 
an explorative attempt.
In addition, the weight of the different tool char-
acterizing the wound at the assessment reflect the 
mutability of the healing process and is unequivocally 
linked to the selection of appropriate dressing that 
should be based on the type of wound, healing status, 
bio-burden present and amount of exudate [35,41]. In 
this scenario, wound quality assessment is also per-
formed to determine if wound is changing, not only 
because it actually may be healing, but also because 
changes provide useful tool to improve the plan of 
care and direct clinical decision-making [31]. In this 
case series the scores, in association with manufac-
ture’s instruction linked to TIME approach, were 
used to direct decision about which HA-containing 
dressing should be apply. The TIME approach is 
based on the goal to remove local barriers to heal-
ing and optimizes the tissue environment to achieve 
wound healing. This concept of wound bed prepara-
tion in human medicine initially arose out of a need 
to address chronic wound but many wounds that fall 
into the traditional classification of “acute” could be 
amenable to management with the wound bed prepa-
ration concept [35]. The TIME concept of human 
medicine, although not specifically studied in the 
veterinary field, partially overlaps wound care guide-
lines reported for animal and are also reported in ani-
mal wound care book [1,42].
The best BWAT score for all wounds was 
obtained the same date of the total epithelializa-
tion while the best WBS score was achieved before. 
This result is justified by the fact that WBS score 
was delineated in human chronic wound to predict 
ultimate wound closure and not to assess the com-
pletion of the process as BWAT does, instead [34]. 
After the obtainment of the best WBS score, all the 12 
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wounds progressively healed until complete epitheli-
alization. In addition using both scales, the greatest 
reduction of the score was obtained in the 1st week 
with a mean decrease of 66.3% for WBS and 33.8% 
for BWAT respect to the admission scores. These 
results confirmed that qualitative assessment was 
especially useful in the early aspects of the healing 
of the acute wound in dogs when often the size of the 
wound do not change [27]. Furthermore, the wound 
that received debridement, even medical or surgical, 
resulted in a larger size that taking into account only 
this data could not revealed an improvement of the 
quality of the wound as instead confirmed by both 
scoring systems (Table-2).
In both scales many are the parameters consid-
ered to elaborate the final score. In human seems that 
exudate control, minimal eschar and decrease size 
have a higher prognostic impact on wound healing 
of chronic wound respect to other such as quality of 
granulation tissue [31,43]. The low number of cases in 
this study did not permit to analyze which parameters 
including in the scales could have the higher impact 
on second intention wound healing in acute wounds in 
dogs. The BWAT scale takes into account more param-
eters than the WBS and nowadays this could allow 
considering it more complete even taking into account 
the higher agreement achieved by two different opera-
tors. However, further studies are needed to delineate 
which parameters are more useful to describe the heal-
ing process in dogs and which are secondary or even 
unnecessary.
Based on these results, HA-containing dressings 
used in this study are easy to apply, well tolerated 
and carry promising results in improving healing of 
acute open wounds in dogs. In this explorative study 
the investigation of prognostic significances of site 
and size of the wound on healing time was not possi-
ble and further studies are necessary, also taking into 
account the comparison between different dressing 
and therapy on healing rate and on cost-benefit ratio. 
The use of scale scoring systems to assess wound 
healing gives consistent results complimentary to 
wound area reduction and the application of this 
assessment tools should be evaluated in veterinary 
medicine. The therapeutic approach based on qual-
ity wound assessment used in this study could be 
considered a primary pilot systemic decision-mak-
ing process easy to follow wound treatment routine 
with HA-based dressing in daily veterinary clinical 
practice.
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